MedPath

Efficacy of Double Carbapenem regimen against Carbapenem resistant Enterobacteriaceae infections

Not Applicable
Completed
Conditions
Health Condition 1: A415- Sepsis due to other Gram-negativeorganisms
Registration Number
CTRI/2021/01/030762
Lead Sponsor
Roopali Somani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
46
Inclusion Criteria

Patients aged 18 years and above of any gender

2. Inpatients with positive culture for Carbapenem Resistant Enterobactericeae

3. Subjects willing to comply with study related procedures

Exclusion Criteria

1. Patients with history of Epilepsy

2. Patients with Creatinine Clearance <30 ml/min

3. Patients with any comorbidities that is known to affect the study outcome

4. Pregnant and lactating women.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath